2766. Comparison of oncologic outcomes of extrahepatic cholangiocarcinoma according to tumor location: perihilar cholangiocarcinoma versus distal bile duct cancer.
Lee JM, Kim H, Sohn HJ, Choi HJ, Kang JS, Han Y, Kwon W, Jang JY.
2760. Prognostic role of tumor subtype and germline BRCA mutation in advanced breast cancer patients treated with palbociclib plus endocrine therapy
Song Yi Park # 1 2 3, Koung Jin Suh # 3 4, Dae-Won Lee 5 6 7, Han Suk Ryu 8 9, Miso Kim 1 10, Se Hyun Kim 3 4, Kyung-Hun Lee 1 10, Tae-Yong Kim 1 10, Jee Hyun Kim 3 4 11, In Ae Park 9, Seock-Ah Im 12 13 14 15
Breast Cancer Res Treat. 2022 Nov;196(1):121-128.Link
2759. Exploratory analysis of biomarkers associated with clinical outcomes from the study of palbociclib plus endocrine therapy in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer
Soohyeon Lee 1, Kyunghee Park 2, Gun Min Kim 3, Kyung Hae Jung 4, Seok Yun Kang 5, In Hae Park 6, Jee Hyun Kim 7, Hee Kyung Ahn 8, Woong-Yang Park 2, Seock-Ah Im 9, Yeon Hee Park 10